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X-linked agammaglobulinemia (XLA)' is an inherited humoral immunodeficiency
involving an intrinsicdefect inB lymphocytedevelopment (1, 2). Theblock indifferen-
tiation is commonly ascribed to an inability of pre-B cells to mature into B cells.
While approximatelynormal numbersofpre-Bcells arepresentin thebone marrow
ofthese patients, the number ofB cells present in the peripheral circulation is <1%
of normal frequencies (3, 4). It has been suggested that XLA might be due to a
defect in attaining complete Ig gene rearrangements (5, 6). However, there are sev-
eral pieces of existing evidence against this hypothesis: (a) two EBVtransformed
celllines froman XLA patientproducednative-sized g chain protein(7, 8); (b)anal-
ysisofboth functional and nonfunctional Hchain allelescloned from a single XLA
B cell line indicated that VHDJ joining can occur normally (9); (c) cell-mediated
immuneresponses are normal in XLApatients (1), making it unlikely thatthe XLA
defect involves Ig gene recombination because B and Tcells appear to useacommon
recombinase system fortheirrespective antigen receptor genes (10); and(d) thesmall
number ofB cells found in the peripheral circulation ofXLA patients express a cell
surface marker phenotype characteristic ofimmature B cells (11). XLA B cells have
ahigh ratio ofcell surface IgM to IgD, and express low levels of HLA class II gene
products and CD21 antigen (4). If the defect in XLA involved only Ig gene rear-
rangement, one would expect those B cells having passed that point in differentia-
tion to mature normally.
One way to study this question would be to determine the clonal diversity of B
cells from patients with XLA. Ifthere were a primary defect in Ig gene rearrange-
ment in this disease, the B cell repertoire within each patient would be expected
to be pauciclonal, with each clone representing a circumvention of the rearrange-
ment defect . Alternatively, if significant B cell clonal diversity were found in XLA
patients, this result would support the hypothesis that the XLA defect involves a
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mechanism apart from Ig gene rearrangement, such as a failure in the normal ex-
pansion or activation of the pre-B or B cell population .
Our goal in this study was to define the degree of clonal diversity in the B cell
repertoire in XLA by analyzing a collection of 18 EBVtransformed B cell lines de-
rived from five patients with this disorder. Previous studies on EBVtransformed
cell lines derived from normal individuals has shown extensive clonal diversity in
such lines (12, 13). Differences in Ig isotype expression between the B cell lines de-
rived from eachpatient provided an initial survey ofclonal diversity; forthe majority
of XLA cell lines, clonal diversity was further assessed by determining V region
gene expression in the productive H and L chain transcripts (V and V,., respec-
tively). This analysis also provided information on the specific sites of VHDJ and
VKJK gene segmentjoining in several XLA B cell lines. Finally, diversity amongthe
XLA B cell lines that expressed similar V region genes was shown by Southern blot
analysis of their H chain gene rearrangement patterns.
Materials and Methods
Patients.
￿
The five patients with XLA were from three unrelated families. All had (a) the
onset of recurrent bacterial infections in the first few years of life; (b) very low concentrations
of serum Igs with failure to make antigen-specific antibody; (c) markedly reduced numbers
of B cells in the peripheral circulation; (d) normal T cell numbers and function; and (e) a
positive family history for a similar illness in maternal male relatives. The patients were be-
tween 10 and 25 yr of age when studied. All patients have been previously reported (14, 15).
Generation ofB Cell Lines.
￿
B cell lines were produced by exposing PBL (for patient BP)
or T cell-depleted PBL (all other patients) to supernatant from the EBVproducing cell line
B95-8. The cells were then cultured at 0.5-1.5 x 106 cells/ml in 24-well culture plates with
PHA (1 :1,000 dilution; Difco Laboratories Inc., Detroit, MI) and Cyclosporine A (0.25 pg/ml,
Sandoz Pharmaceuticals, East Hanover, NJ). The T cell-depleted lymphocytes were sup-
plemented with irradiated T cells at 106 cell/ml.
RNA Isolation and Analysis.
￿
Total cellular RNA was isolated by the method of Schibler
et al. (16). The poly(A)' fraction was enriched by affinity chromatography on oligo-dT-cel-
lulose columns (Collaborative Research, Lexington, MA). Northern blot analysis to screen
for V3 gene family expression was done as described by Nelson et al. (17), with the excep-
tion that nylon membranes were used (Nytran; Schliecher & Schuell, Inc., Keene, NH).
Northern blots using the mouse V7183 probes were washed under high stringency condi-
tions (0.1 x SSC, 0.2% SDS at 52'C for 30 min). RNA blots using the VK Daudi probe for
VKI/IV gene subgroup expression were similarly washed. A positive signal using either probe
among the XLA lines was always comparable with the intensity of that observed using the
respective C region probes, indicating that the positive signal was not due to a contaminating
cell population. Direct RNA sequencing by primer extension was performed according to
Geliebter et al. (18) using human Cp,l, V , or CK exon-specific oligonucleotides.2
DNA Isolation andAnalysis.
￿
High molecular weight genomic DNA was obtained following
the procedure ofPerry et al. (19). Southern blot analysis was performed as described by Schuler
et al. (20) with the substitution of nonfat dry milk for Denharts' reagent (at 1%).
Cloned DNA Probes.
￿
The mouse V7183 probe was a gift of Dr. Roy Riblet (Medical Bi-
ology Institute) and has been described (21). The human V,, Daudi probe has been described
in detail (22). Human R and K C region probes were the same as used in reference 23, and
the human J. region probe was the 4.5-kb J' Barn HI/Hind III fragment subcloned from
the phage clone CH28-6 (24).
2 Synthesized by the DNA Synthesis Core Lab ofthe Cancer Center of Wake Forest University, sup-
ported by National Institutes of Health grant 12197 from the National Cancer Institute.ANKER ET AL.
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Results
Ig Protein Expression among XLA B Cell Lines.
￿
EBV transformation of PBL from
five XLA patients gave rise to one cell line from patients JeB and SD, eight lines
from patients JP and CP, and 22 lines from patient BP Because our goal was to
conduct amolecular analysis on Ig gene structure andexpression in these cell lines,
we selected only those lines that were homogeneous for Ig isotype expression; 18
of the total 40 XLA B cell lines were shown by cytoplasmic immunofluorescence
to produce a single H and L chain isotype (some lines contained 0-5% of cells ex-
pressing other isotypes; these minor contaminants did not compromise our anal-
ysis). B cell lines generated from individual patients were heterogeneous for isotype
expression (Table I). For example, one arc-, one 1AX-, and three AK-producing lines
were generated from patientJP, while cells from patient CP gave one-YK-, one -yX-,
and two JAK-positive lines. The variability in Ig isotype expression among some of
thelines parallelswhat has been observed by staining untransformedPBLfrom XLA
patients (4) and suggests that at least limited B cell clonal diversity exists in certain
XLA patients. However, this diversity could be due to different precursor clones
formingtherepertoire, or due to H chainclass switching and secondary Kto Aswitches
(25) in a pauciclonal B cell population .
Ig mRNA Expression amongXLA B Cell Lines.
￿
To examine theissueofclonal heter-
ogeneity further, Ig H and L chain mRNA from the majority of XLA B cell lines
was analyzed to define the diversity in V region gene use. We chose to focus on cell
linesproducingu and « chains because ofthe well-characterized nature of the human
TABLE I
Diversity of Ig Expression among XLA B Cell Lines
Rearranged V,D, and Jx elements are shown for those u mRNA that were
tested for V7183 hybridization and sequenced; tentative V assignment is
based on >80% sequence identity with a prototype V, gene of the respective
family (insufficient sequence data for BP3 prohibited a tentative V, designa-
tion).
Cell line Isotpye
V7183
hybridization
VDJ
rearrangement'
VKI/IV
hybridization
JeB AK + V3 (D?/J4) +
SDI AK + V3 +
JP3 UK ND ND
JP4 AK - V4 (D4/J5) -
JP7 kX ND
JP11 AK - V1 (D4/J5) -
JP12 rUK - V1 (D?/J4) -
CP1 /AK + V3 (D21-7/J4) +
CP3 -y ND
CP11 'YK ND ND
CP101 AK - V,4 (D?/J6) +
BP3 AK + (D?/J6) -
BP4 AK + -
BP7 AX ND
BP12 AK - V4 (D?/J4) +
BP19 rUK + +
BP20 6X ND
BP24 AK + +2112
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i . and«C region exon sequencesto which complementaryRNA sequencing primers
could be made . An initial goal was to determine whether each AK-positive line ex-
pressedA and K transcripts of a size corresponding to a productivemRNA (2.7 and
2 .4 kb for Am and p .s mRNA, and 1 .2 kb for K mRNA). Northern blotting of poly
A-containing cytoplasmic RNA from each line was done using a human A and is
C region probes (pHuC/ , and pHuCK; reference 23) . AllXLAB cell lines positive
for A and K protein by immunofluorescence expressed native-sized Am, As, and K
mRNA transcripts, and the presence oftruncated or aberrant CA.- orCK-hybridizing
RNA transcripts was not observed (Fig . 1, A and C) . Another measure of the func-
tional nature of theA and « transcripts in theseXLA B cell lines was a normal pat-
tern forVDJ and VKJK gene rearrangement (Fig. 2, a and b, respectively) . RNA
sequencing of A, and K mRNA in the region of gene rearrangement for several of
the XLA lines showed that the sites of gene joining exhibited a normal degree of
junctional diversity and occurred well within the usual range of codon positions
reported forproductively rearranged human andmouseIg genes(26) . The presence
of an open translational reading frame across theV(D)J region in all cell lines ex-
amined was also consistent with their expression of Ig protein reactive with anti-
bodies specific for the i, and K C regions.
After establishing that the AK-producingXLA B cell lines expressed functional
i . and K transcripts of normal primary structure, V gene use was examined by
FIGURE 1 .
￿
Northern hybridization analysis of IgmRNA in ILK-producing XLAB cell lines . (A)
Hybridization with humanCp probe; (B) hybridization with mouseV7183 probe ; (C) hybrid-
ization with human C,, probe ; and (D) hybridization with humanVK Daudi probe. In all blots,
5 I .tg of poly(A)' total cellular RNA is loaded per lane . The variability in the signal intensity
between some XLA B cell lines for IL and/or K mRNA is due to variation in the intracellular
steady-state levels of these transcripts .a Vh-D-Jh sequence
a
a GTG CAG CCT GGG AGG TCC CTG AGA
a TTC AGT AGC TAT GGC ATG CAC TOO
20
CTC TCC TGT
6-T CG- -A6
a GAG TOO GTG GCA CTT ATA TOO TAT GAT GG AGT
b
￿
G TGG G-C TCA CCT A-G TOO T-- G-- G-T -G-
GO
a CTG CM ATG MC AGC CTG AGO ACC GAG GAC
b CIA CM ATG MC AGC CTG AGO ACC GAG SAC
c CTG AGO CTG ACC TCT GCC ACC G-C -C6 GA
d CTG MC CTC ACC TCT GIG ACC GGC AGO GA
e ATG GAG CTG AGC AGC CTG AG TCT GAA GAC
f ATG GAG CTG AGC AGC CTG AG TCT GM GAC
9
h CTG MG CTG AGC TCT GIG ACC GGC GCG GC
D region
a GC CCT ATA GCA GAT GOT GGG GGG
b ACC TCG GGC TCC TAT GOT TCG GGG AGT TAT
c GGC CCG GGC TCC TAT GC MT AGT ACT TAT
d GCG G-A GGC TAT TOT AGT AGT ACC ACT 6C6
e AGO GCC TCT GTA TOT AGT AGT ACC AGC TOT
f GAG GGG CCT AGC AGT GGC TCG GCG TTA ACC
9 CG CTC CST TAT GGG AGO GAG GCT AGC TGT
h GGC AGO GGG CCG TAT TAC TAT GT AGT AGT
Jh region
￿
101
a
￿
GC TAC TOO G
b
￿
TAC TIT 6AC TAC TOO GGC
c
￿
TAC TAC GO
d
￿
MC TOG TIC GA
e
￿
MC TOO ATC
f
￿
TTT GAC TAC TOO GGC
9 TAC TAC TAC TAC TAC GOT AT
h
￿
TTT GAC TA- TOO GGC
b
a
1
b
V.-J. sequence
CCC
ANKER ET AL.
6
T GGG GOA GGC GTA
GCA GCG TCT GOA TIC ACC
40
OCT CCA OGG MG 666 CTG
60
MT AM TAC TAT CG GAC
ACC ACA TAC TAC GCA GAC
94
AC6 OCT 6TG TAT TAC TOT GCG AG
ACG 6CC GTA TAT TAC TOT GCG AM
AC6 OCT GTG TAT TAC TOT GCG AG
CCG GCC GTG TAT TAC TOT KG ASA
AGO 6C6 OTC TAT TAC TGT GCO AAA
AC6 OCT GTG TAT TAC TGT GCG AGA
ACG 6CC 6TG TAT TAC TOT GCG AG
AC6 OCT 6TG TAT TAC TGT 6C6 AGO
CG GGG
TAT CCC COG
C-A 666 ATC OGG
6TC TOO COT
GGC CAA ACC MG TCC TCC 666 TC6 AC6
so
T GG
ACG 6M TCC -G6 -TC CCT GAC CG --C AGT GGC A-C GGG
TAT OCT GCA TCC AGT TTG CM AGT GGG 6CC CCA TCA AQC TIC AGT GGC AGT 66A
70
￿
Vs region
a TCT GGG ACA A-A TTC ACT CTC ACC ATC AGC AGC CT6 CAG CCT GT GT 77T GCA ACT
i TCT GGG AGC AG TTC ACT CTC ACC ATC A-- AGC 6TG CAG OCT 6M GT 6TG GCA OTT
b TCT GGG ACA GAT TTC ACT CTC ACC ATC AGC AGT CT6 CM CCT GU1 GT ITT GCA OCT
90
￿
J. region
a TAT TAC TGC CM CAG TAT MT AGT TTT TOO
￿
AC6 TTC GGC C-A G66 AC
i TCT TAC TGT -A- CM TAT TAT AGT ACT CCT CTA
￿
AC6 TTC GGC CM 666 AC
b TAC TAC TGT CM CAG ACT TAC AG ACC CCC COG CAG
￿
ACG TTC 6GC CM 666
2113
FIGURE 2.
￿
(a) RNA sequence of the
productive p chain mRNA in seven
XLA B cell lines within the region of
VDJ gene rearrangement. A Cpl
exon-specificoligonucleotide(5'-GTT
GGGGCGGATGCACTCC-3') was
used to prime cDNA synthesis forthis
region of the p transcript; a V-spe-
cific oligonucleotide wasused forcom-
pletion of the 5' end of the sequence
in the case of CPI and JeB. The V
codons arenumbered accordingto the
aminoacid residue inthemature form
of the H chain protein (as according
to Kabat et al. [26)). (b) RNA se-
quences of three functional XLA K
transcripts across the VKJK junction.
ACKexon-specific oligonucleotide (5'-
GACAGATGGTGCAGCCAC-3) was
used. Numberingis as in a. Individual
sequencesare designated as follows: a,
JeB; b, CP1; c, CPIOI; d, JP4; e, JPII;
f, JP12; g, BP3; h, BP12; i, SDI.
Northern hybridization analysis with the mouse V,a7183 probe, which crosshy-
bridizes with human VH region sequences belonging to the VH3 gene family (27,
28). Using highly stringent hybridization and washing conditions, 7 ofthe 12 AK-
producing lines expressed a productive u mRNA that hybridized with the V.7183
probe (Fig. 1 B and summarized in Table I). The apparent heterogeneity in V gene
use amongXLA B cells was confirmed by RNA sequencing ofthe 3' V region for
several VH7183+ and VH7183- XLA 1A mRNA (Fig. 2 a). The V7183-hybridizing
14 transcripts, as expected, contained sequences similar to V3 genes (76-96% se-
quence identity when compared with eight germline and nine cDNA V.3 gene se-
quences; references 28 and 29). The VH7183- It transcripts had differing sequences
within this region; some cell lines such as JP4 and BP12 contained V4-like se-
quences (30), whileJPli andJP12 had V1-like sequences (28). The sequence data
in Fig. 2 a also shows that different D andJI, gene segments were utilized to code
Vh region
a TCC GTG MG GGC CGA TTC ACC ATC TCC AG 6AC MC TCC M6 MC AC6 CTS TAT
b TCC GTG MG GGC CGA --C ACC -TC TCC AG GAC -AT TCC -A6 AAC ACA CTG TAT
c AC ACG TCC AAG AAC --A TIC TCC
d GTA GGC AC6 TCC AAG MC CAC TIC TCC
e A TCC A-6 AGC ACA GCC TAC
f TCC 6C6 AGC ACA 6CC TAC
9
h TCC M6 AAC CAG TIC TCC2114
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for the productive A RNA transcripts in most XLA lines, and that where similar
gene segments were used, the site of their rearrangement differed (e.g .,JP4vs . JP11) .
Taking the Northern hybridization andRNAsequence data together, itwasapparent
that variousV genes were utilized by theXLA B cells, and more importantly, that
different B cell lines derived from a single patient expressed a heterogeneous V ,
D, and J,, gene repertoire.
Clonal diversity within the /,K-producing set ofXLA lines was further shown by
the pattern of K light V region use . K mRNA from each JtK+ line was probed with
the productive VIC gene cloned from the human Burkitt lymphoma Daudi (22) ; a
similarVK probe hybridizes to N75To of «mRNA molecules isolated from untrans-
formed human splenic B cells (31) . The Northern hybridization results using the
VK Daudi probe established that the cell lines BP3 and BP4 were clonally distinct
from lines BP19 and BP24 (Fig . 1 D) . In addition, this experiment indicated that
differentVK genes were utilized, and that certain VV, gene combinations were
not selectively expressed in the B cell repertoire ofXLA patients . Examination of
the partial VK sequences of the threeXLA B cell lines shown in Fig. 2 b indicated
that different VK genes were represented even within theVK Daudi-hybridizing set
of XLA-derived K mRNA .
Genomic Analysis of Ig Gene Rearrangements in XLA B Cell Lines .
￿
As a final test of
clonal diversity, we analyzed the gene rearrangement patterns for the Ig H chain
locus of the three JUK` JP-derived cell lines and the four IAK+, V3-like BP cell lines
by Southern blot hybridization using a J region-specific probe (Fig. 3) . Because
FIGURE 3 . Ig H chain gene
rearrangements in multiple B
cell lines of two XLA patients .
Southern blot analysis using a
cloned humanJ region probe
(Barn HI/Hind III fragment ;
reference 24) demonstrated that
each B cell line had undergone
distinct IgH gene rearrangement
events . Restriction digests were
chosen to include the entire J
region on a single DNA frag-
ment : JPDNAwas digested with
Xba I,BPDNAwith Hind III.
Note that eachXLA B cell line
has two J-hybridizing DNA
fragments (BP 24 has two co-
migrating fragments in the
Hind III digest, but two separ-
able fragments using other re-
striction digests), showing that
both H chain alleles undergo
rearrangement . The very light
bands present in some of the
XLA lines represent submolar
amounts of DNA from the
minor contaminants in these
lines (0-57o) .ANKER ET AL.
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H chain gene rearrangement occurs early in B cell differentiation, all descendants
of a single pre-B cell precursor will have the same structure of VDJ joining, and
hence, the same restriction fragment hybridization pattern in this region of the ge-
nome. All three JP lines and all four V-3-like BP lines possessed different J.-
hybridizing restriction fragments, definitively showing that each B cell line was de-
rived from an independent B cell precursor.
Discussion
The gene defect in XLA is intrinsic to the B cell lineage (2, 32) and results in
a failure to produce B lymphocytes (1). The nature of this gene defect remains un-
known. Because synthesis of a functional Ig molecule is the hallmark of normal B
cell development, abnormal or inefficient rearrangement of the genes required for
Ig production has been considered a possible explanation for the defect in XLA.
In support of this possibility, Schwaber et al. (5) presented data demonstrating the
occurrence of it transcripts lacking V regions in three bone marrow-derived pre-
B cell lines from XLA patients. However, it has been shown that the earliest pre-B
cells in the mouse can produce these similarly truncated /, chains (33), suggesting
that thesehuman pre-B cell lines may representanormal, early stage in B cell devel-
opment. Amongthe pre-B cells that do differentiate into B cells in individuals with
XLA, our results indicate that both H and L chain gene rearrangement occur in
a normal fashion. The sites of V-D, D-J., and V,-J, gene joining all occur within
the usual rangeof nucleotide positions, they occur normally independent ofthe type
ofV D, orJ gene segment involved, and allthe normal modes forintroducing struc-,
tural variability at the time ofIg genejoining, such as junctional diversity and gener-
ation of G/C nucleotide-rich non-DNA-encoded N segments, appear to be active.
Further, our results indicated that the gene defect in XLA does not inhibit func-
tional rearrangement of L chain genes, which is a salient point because the XLA
defect is phenotypically expressed as an inability of pre-B cellsto develop into Bcells.
In light of these findings, can Ig gene recombination defect(s)be ruled out as the
molecular basis for B cell deficiency in XLA? The obvious rejoinder to using Ig-
producing B cell lines from such patients is that one is selecting for the rare cells
that make it through the block in H and/or L chain gene joining. If this were the
case, then we would expect to find a very limited degree of clonal diversity among
the B cell lines derived from each individual patient. This situation is in fact ex-
emplified by an animal model of lymphoid immunodeficiency, the leaky scid mouse
(34). Although these mice have detectable serum Ig levels, the B cell repertoire is
pauciclonal, consisting of only one to three clones of Ig-producing B cells per an-
imal. As the scid defect appears to reflect an inability to efficiently accomplish func-
tional rearrangement of Ig and TCR genes (20, 35), the Ig+ B cells in leaky scid
mice likely represent "escapees" from the defect. The argument that XLA is an anal-
ogous situation to the leaky scid mouse is contradicted by thestriking clonal diversity
observed amongthe CP-, JP-, and BP-derived B cell lines; all five ILK' BP lines arose
from different precursor clones, as did all three JP and both CP
1AK+ cell lines. As
various VK genes are represented in the XLA B cell lines, the ability of XLA pre-B
cells to undergo Lchain gene rearrangement cannot be due to a particular V,, gene
or gene subgroup that more readily circumvents a putative rearrangement defect.
This point is also relevant for H chain gene rearrangementin XLA, since extremely
varied patterns of somatic rearrangements are apparent in the JH region of the2116
￿
B CELL CLONAL DIVERSITY IN X-LINKED AGAMMAGLOBULINEMIA
different cells (Figs. 2 a and 3). The B cell repertoire in XLA patients, while much
smaller in the total number ofIg-producing B cells, arises from multiple pre-B cell
clones and is diverse in the sense that independent rearrangement events created
the few B cells that are present in vivo.
Alood at the fine structure of the Ig genes in the region of rearrangement for
several ofthe XLA B cell lines indicates that B cell clonal diversity in these patients
did not come at any one stage during differentiation. For the threeJP- and two BP-
derived lines analyzed at the sequence level: (a) the elements and sites involved in
D-J, genejoining are distinct (the first event in H chain gene rearrangement); (b)
the type of VH gene to join to a given D/JH combination varies (e.g., JP4 is
V.4/D4/j,,5 vs. JP11 being VH1/D4/JH5); and (c) different L chain gene segments
are utilized (e.g., BP3 differs from BP12 in V, gene expression). The presence of
an apparent somatic mutation in theJH5 region ofJP11 (the T-"A transversion in
codon 101 was confirmed in two separate sequences) and the occurrence ofH chain
classswitchingevent in several linesindicatethat structural changes inIggenes gener-
ally associated with the mature B lymphocyte stage ofdifferentiation also can take
place in XLA B lymphocytes.
An alternative explanation for the defect in B lymphocyte differentiation in XLA
may be due to a more generalized problem in B cell growth and clonal expansion.
We havepreviously hypothesized that the defect in XLA does not lieat asingle point
in differentiation from pre-B cell toB cell, but instead affects B cells at several stages
ofmaturation, resulting indecreasedproliferation or activation ofB cells throughout
differentiation (4). Although patients withXLA are said to have "normal" numbers
ofpre-B cells, the actual number is somewhat decreased compared with controls.
In a study by Pearl et al. (3) using age-matched children, 7.1 t 7.5% of the lym-
phoid cells in the bone marrow ofnormals were pre-B cells, but in boys withXLA,
3.8% ofthe lymphoid cells were pre-B cells (range 0.7-11.2%). Compared with pre-
B cells from controls, a smaller proportion ofthe pre-B cells from the XLA patients
were synthesizing DNAasmeasured byautoradiography(3). Also, EBVtransformed
B cell lines from XLA patients multiply at a greatly retarded rate compared with
EBV cell lines from normal individuals (our unpublished observation). The greatly
depressed production ofB lymphocytes in patients with XLA is unlikely to be due
to abnormal production of a growth or differentiation factor. Previous studies by
one ofus(2), demonstratingnonrandomXchromosomeinactivation inB cellsfrom
obligate carriers ofXLA, suggestthat the geneproduct is not transportablebetween
cells. Candidate mechanisms behind the XLA defect currently include problems
in expression ofa cell surface receptor for a growth or differentiation factor, adefect
in a signal transduction pathway, or the inability of a nuclear-localized trans-acting
molecule to interact at its site of action on the gene. The findings in the present
study, showing normal VH and V,, rearrangements, clear clonal diversity within pa-
tients, and expression of a varied VH and V,, gene repertoire, provide support for
the hypothesis that the defect in XLA is exerted on a B cell-specific process that
is unrelatedto the generationandexpressionoffunctional Iggenes, butthatis nonethe-
less critical to the proper development of B lymphocytes.
Summary
Igprotein and mRNA expression was examined in a collection of 18 monoclonal
EBVtransformed B cell lines derived from five patientswithX-linked agammaglob-ANKER ET AL.
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ulinemia (XLA). A diversity of H and L chain isotypes were synthesized by these
lines: the majority (12 lines) expressed 1.4K chains, while p,X (two lines), yK (one), yA
(one), A (one), and aK (one) isotype expression was also observed. For all the JAK-
producing XLA B cell lines, the p and K mRNA transcripts were of native size, and
sequence analysis across the regions of VDJH and VKJK joining showed that Ig gene
rearrangements occurred in a typical manner. A variety of VHDJ and VKJK gene
rearrangements were observed, not only within the set of p,K + XLA B cells as a
whole, but also among the cell lines derived from single patients. Southern blot anal-
ysis for genomic Ig H chain gene rearrangements was done to fully assess the extent
of clonal heterogeneity among multiple ILK' XLA B cell lines derived from two pa-
tients; all the B cell lines possessed distinct gene rearrangement patterns demon-
strating their clonal unrelatedness. Our findings indicate that the B cell repertoire
in individual XLA patients is clonally diverse and that it is unlikely that the defect
in B cell differentiation in XLA is the result of inefficient or ineffective rearrange-
ment of Ig H or L chain genes. Rather, this study provides support for the idea
that the XLA defect relates to a more generalized cellular function, such as regulating
the proliferation and/or clonal expansion of cells of the B lymphoid lineage.
We thankDrs. Phil Leder, Hans Zachau, and Roy Riblet for providing probes, Persymphonie
Brown Millerand Scott Palmer for technical assistance, and Teresa Hire and MelissaJackson
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